Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Veenstra

Showing results (21-30 of 284) with videos related to

Pageof 29
Sort By:
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Productivity loss by cancer stage in patients newly diagnosed with hepatocellular carcinoma: A claims database analysisSpencer J Cheng, Aasthaa Bansal, David L Veenstra
Infection Control and Hospital Epidemiology|July 6, 2000
The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?S Saint, D L Veenstra, B A Lipsky
Pharmacoeconomics|May 27, 1999
The use of meta-analysis in cost-effectiveness analysis. Issues and recommendationsS Saint, D L Veenstra, S D Sullivan
JAMA|March 28, 2013
The economics of genomic medicine: insights from the IOM Roundtable on Translating Genomic-Based Research for HealthW Gregory Feero, Catherine Wicklund, David L Veenstra
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 28, 2015
A Framework for Prioritizing Research Investments in Precision MedicineAnirban Basu, Josh J Carlson, David L Veenstra
Health Services Research|September 9, 2005
Implications of the genetics revolution for health services research: pharmacogenomics and improvements in drug therapyK A Phillips, D L Veenstra, W Sadee
Pharmacoepidemiology and Drug Safety|May 5, 2020
Medication persistence of targeted immunomodulators for plaque psoriasis: A retrospective analysis using a U.S. claims databaseNathaniel Hendrix, Zachary A Marcum, David L Veenstra
Journal of Managed Care & Specialty Pharmacy|July 27, 2016
Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysisMichael A Serbin, Gregory F Guzauskas, David L Veenstra
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 25, 2003
A review of selected patient-generated outcome measures and their application in clinical trialsKavita K Patel, David L Veenstra, Donald L Patrick
Pharmacoeconomics|January 21, 2004
Health economic evaluation of non-melanoma skin cancer and actinic keratosisMitchell K Higashi, David L Veenstra, Paul C Langley
Pageof 29

Showing results (21-30 of 284) with videos related to

Sort By:
Pageof 29
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Productivity loss by cancer stage in patients newly diagnosed with hepatocellular carcinoma: A claims database analysisSpencer J Cheng, Aasthaa Bansal, David L Veenstra
Infection Control and Hospital Epidemiology|July 6, 2000
The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?S Saint, D L Veenstra, B A Lipsky
Pharmacoeconomics|May 27, 1999
The use of meta-analysis in cost-effectiveness analysis. Issues and recommendationsS Saint, D L Veenstra, S D Sullivan
JAMA|March 28, 2013
The economics of genomic medicine: insights from the IOM Roundtable on Translating Genomic-Based Research for HealthW Gregory Feero, Catherine Wicklund, David L Veenstra
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 28, 2015
A Framework for Prioritizing Research Investments in Precision MedicineAnirban Basu, Josh J Carlson, David L Veenstra
Health Services Research|September 9, 2005
Implications of the genetics revolution for health services research: pharmacogenomics and improvements in drug therapyK A Phillips, D L Veenstra, W Sadee
Pharmacoepidemiology and Drug Safety|May 5, 2020
Medication persistence of targeted immunomodulators for plaque psoriasis: A retrospective analysis using a U.S. claims databaseNathaniel Hendrix, Zachary A Marcum, David L Veenstra
Journal of Managed Care & Specialty Pharmacy|July 27, 2016
Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysisMichael A Serbin, Gregory F Guzauskas, David L Veenstra
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 25, 2003
A review of selected patient-generated outcome measures and their application in clinical trialsKavita K Patel, David L Veenstra, Donald L Patrick
Pharmacoeconomics|January 21, 2004
Health economic evaluation of non-melanoma skin cancer and actinic keratosisMitchell K Higashi, David L Veenstra, Paul C Langley
Pageof 29